NCT03899987 - Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 29, 2019

Primary Completion Date

June 12, 2025

Study Completion Date

November 29, 2026

Conditions

Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8Stage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8

Interventions

DRUG

EC Aspirin

Given PO

PROCEDURE

Radical Prostatectomy

Undergo radical prostatectomy

BIOLOGICAL

Recombinant Interferon Alfa-2b

Given IV

DRUG

Rintatolimod

Given IV

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo